Nanostructures of Diamond, Graphene Oxide and Graphite Inhibit CYP1A2, CYP2D6 and CYP3A4 Enzymes and Downregulate Their Genes in Liver Cells

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2018 Dec 28

PMID 30587978

Citations 8

Authors

Barbara Strojny

Ewa Sawosz

Marta Grodzik

Slawomir Jaworski

Jaroslaw Szczepaniak

Malwina Sosnowska

Mateusz Wierzbicki

Marta Kutwin

Sylwia Orlinska

Andre Chwalibog

Affiliations

Soon will be listed here.

Abstract

Introduction And Objective: Currently, carbon nanostructures are vastly explored materials with potential for future employment in biomedicine. The possibility of employment of diamond nanoparticles (DN), graphene oxide (GO) or graphite nanoparticles (GN) for in vivo applications raises a question of their safety. Even though they do not induce a direct toxic effect, due to their unique properties, they can still interact with molecular pathways. The objective of this study was to assess if DN, GO and GN affect three isoforms of cytochrome P450 (CYP) enzymes, namely, CYP1A2, CYP2D6 and CYP3A4, expressed in the liver.

Methods: Dose-dependent effect of the DN, GO and GN nanostructures on the catalytic activity of CYPs was examined using microsome-based model. Cytotoxicity of DN, GO and GN, as well as the influence of the nanostructures on mRNA expression of CYP genes and CYP-associated receptor genes were studied in vitro using HepG2 and HepaRG cell lines.

Results: All three nanostructures interacted with the CYP enzymes and inhibited their catalytic activity in microsomal-based models. CYP gene expression at the mRNA level was also downregulated in HepG2 and HepaRG cell lines. Among the three nanostructures, GO showed the most significant influence on the enzymes, while DN was the most inert.

Conclusion: Our findings revealed that DN, GO and GN might interfere with xenobiotic and drug metabolism in the liver by interactions with CYP isoenzymes responsible for the process. Such results should be considered if DN, GO and GN are used in medical applications.

Citing Articles

Human Multi-Lineage Liver Organoid Model Reveals Impairment of CYP3A4 Expression upon Repeated Exposure to Graphene Oxide.

Romaldini A, Spano R, Veronesi M, Grimaldi B, Bandiera T, Sabella S Cells. 2024; 13(18.

PMID: 39329726 PMC: 11429598. DOI: 10.3390/cells13181542.

The Potentiating Effect of Graphene Oxide on the Arylhydrocarbon Receptor (AhR)-Cytochrome P4501A (Cyp1A) System Activated by Benzo(k)fluoranthene (BkF) in Rainbow Trout Cell Line.

Valdehita A, Fernandez-Cruz M, Navas J Nanomaterials (Basel). 2023; 13(18).

PMID: 37764529 PMC: 10534689. DOI: 10.3390/nano13182501.

Short-Term Intravenous Administration of Carbon Nano-Onions is Non-Toxic in Female Mice.

Tan Y, Thomsen L, Shrestha N, Camisasca A, Giordani S, Rosengren R Int J Nanomedicine. 2023; 18:3897-3912.

PMID: 37483316 PMC: 10361275. DOI: 10.2147/IJN.S414438.

Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.

Cameron S, Sheng J, Hosseinian F, Willmore W Int J Mol Sci. 2022; 23(14).

PMID: 35887304 PMC: 9323783. DOI: 10.3390/ijms23147962.

Sub-Lethal Concentrations of Graphene Oxide Trigger Acute-Phase Response and Impairment of Phase-I Xenobiotic Metabolism in Upcyte Hepatocytes.

Romaldini A, Spano R, Catalano F, Villa F, Poggi A, Sabella S Front Bioeng Biotechnol. 2022; 10:867728.

PMID: 35662849 PMC: 9161028. DOI: 10.3389/fbioe.2022.867728.

References

Lin J, Lu A . Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet. 1998; 35(5):361-90. DOI: 10.2165/00003088-199835050-00003. View

Zanger U, Schwab M . Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138(1):103-41. DOI: 10.1016/j.pharmthera.2012.12.007. View

Saptarshi S, Duschl A, Lopata A . Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology. 2013; 11:26. PMC: 3720198. DOI: 10.1186/1477-3155-11-26. View

Frohlich E, Kueznik T, Samberger C, Roblegg E, Wrighton C, Pieber T . Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. Toxicol Appl Pharmacol. 2009; 242(3):326-32. DOI: 10.1016/j.taap.2009.11.002. View

Moorthy B, Chu C, Carlin D . Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci. 2015; 145(1):5-15. PMC: 4408964. DOI: 10.1093/toxsci/kfv040. View

Wierzbicki M, Jaworski S, Kutwin M, Grodzik M, Strojny B, Kurantowicz N . Diamond, graphite, and graphene oxide nanoparticles decrease migration and invasiveness in glioblastoma cell lines by impairing extracellular adhesion. Int J Nanomedicine. 2017; 12:7241-7254. PMC: 5634373. DOI: 10.2147/IJN.S146193. View

Afsahi S, Lerner M, Goldstein J, Lee J, Tang X, Bagarozzi Jr D . Novel graphene-based biosensor for early detection of Zika virus infection. Biosens Bioelectron. 2017; 100:85-88. DOI: 10.1016/j.bios.2017.08.051. View

Munro A, Girvan H, Mason A, Dunford A, McLean K . What makes a P450 tick?. Trends Biochem Sci. 2013; 38(3):140-50. DOI: 10.1016/j.tibs.2012.11.006. View

El-Sayed R, Bhattacharya K, Gu Z, Yang Z, Weber J, Li H . Single-Walled Carbon Nanotubes Inhibit the Cytochrome P450 Enzyme, CYP3A4. Sci Rep. 2016; 6:21316. PMC: 4761960. DOI: 10.1038/srep21316. View

10.

Atif R, Inam F . Reasons and remedies for the agglomeration of multilayered graphene and carbon nanotubes in polymers. Beilstein J Nanotechnol. 2016; 7:1174-1196. PMC: 5082316. DOI: 10.3762/bjnano.7.109. View

11.

Tanum J, Heo J, Hong J . Spontaneous Biomacromolecule Absorption and Long-Term Release by Graphene Oxide. ACS Omega. 2018; 3(5):5903-5909. PMC: 6045413. DOI: 10.1021/acsomega.8b00537. View

12.

Hitoshi K, Katoh M, Suzuki T, Ando Y, Nadai M . Changes in expression of drug-metabolizing enzymes by single-walled carbon nanotubes in human respiratory tract cells. Drug Metab Dispos. 2011; 40(3):579-87. DOI: 10.1124/dmd.111.043455. View

13.

Wang F, Yu L, Monopoli M, Sandin P, Mahon E, Salvati A . The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine. 2013; 9(8):1159-68. DOI: 10.1016/j.nano.2013.04.010. View

14.

Ahmed S, Zhou Z, Zhou J, Chen S . Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics Proteomics Bioinformatics. 2016; 14(5):298-313. PMC: 5093856. DOI: 10.1016/j.gpb.2016.03.008. View

15.

Grodzik M, Sawosz E, Wierzbicki M, Orlowski P, Hotowy A, Niemiec T . Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo. Int J Nanomedicine. 2011; 6:3041-8. PMC: 3230570. DOI: 10.2147/IJN.S25528. View

16.

Gu Z, Yang Z, Chong Y, Ge C, Weber J, Bell D . Surface Curvature Relation to Protein Adsorption for Carbon-based Nanomaterials. Sci Rep. 2015; 5:10886. PMC: 4455116. DOI: 10.1038/srep10886. View

17.

Ostadhossein F, Mahmoudi N, Morales-Cid G, Tamjid E, Navas-Martos F, Soriano-Cuadrado B . Development of Chitosan/Bacterial Cellulose Composite Films Containing Nanodiamonds as a Potential Flexible Platform for Wound Dressing. Materials (Basel). 2017; 8(9):6401-6418. PMC: 5512916. DOI: 10.3390/ma8095309. View

18.

Gao Y . Carbon Nano-Allotrope/Magnetic Nanoparticle Hybrid Nanomaterials as T2 Contrast Agents for Magnetic Resonance Imaging Applications. J Funct Biomater. 2018; 9(1). PMC: 5872102. DOI: 10.3390/jfb9010016. View

19.

You R, Lu W, Shan M, Berlin J, Samuel E, Marcano D . Nanoparticulate carbon black in cigarette smoke induces DNA cleavage and Th17-mediated emphysema. Elife. 2015; 4:e09623. PMC: 4612775. DOI: 10.7554/eLife.09623. View

20.

Ye M, Tang L, Luo M, Zhou J, Guo B, Liu Y . Size- and time-dependent alteration in metabolic activities of human hepatic cytochrome P450 isozymes by gold nanoparticles via microsomal coincubations. Nanoscale Res Lett. 2014; 9(1):642. PMC: 4266508. DOI: 10.1186/1556-276X-9-642. View